Skip to main content

Lower Prevalence of Employment Seen for Survivors of Childhood Cancer

Medically reviewed by Carmen Pope, BPharm. Last updated on May 12, 2024.

By Elana Gotkine HealthDay Reporter

FRIDAY, May 10, 2024 -- Adult survivors of childhood cancer have declines in employment and increases in health-related unemployment compared with the general population, according to a study published online May 10 in JAMA Network Open.

Neel S. Bhatt, M.B.B.S., M.P.H., from the Fred Hutchinson Cancer Center in Seattle, and colleagues conducted a retrospective cohort study of five-year cancer survivors diagnosed at age 20 years or younger between 1970 and 1986 to examine longitudinal trends in employment. Sex-stratified employment status at baseline (2002 to 2004) and follow-up (2014 to 2016) was compared to rates from the general population.

The researchers found that the prevalence of full-time or part-time employment at baseline was 71.3 and 85.3 percent for female and male participants, respectively, and prevalence at follow-up was 64.8 and 77.3 percent, respectively; standardized prevalence ratios declined over time (from 1.01 to 0.94 for women and from 0.96 to 0.92 for men). There was an increase noted in the prevalence of health-related unemployment (11.6 to 17.2 percent for women; 8.1 to 17.1 percent for men); compared with the general population, the standardized prevalence ratio remained elevated and decreased over time (3.78 to 2.23 for women; 3.12 to 2.61 for men). Of the survivors who were employed fulltime at baseline, 19.2 and 12.8 percent of women and men, respectively, experienced a negative employment transition.

"A multidisciplinary approach that includes survivors, clinicians, and employers is likely needed to address long-term employment needs of cancer survivors," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

2024 ASCO Annual Meeting to Focus on Clinical Cancer Research Impacting Patient Care

THURSDAY, May 23, 2024 -- The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting is being held May 31 to June 4, 2024, in Chicago and online. The theme of this...

Metformin Use Linked to Lower Odds of Myeloproliferative Neoplasms

THURSDAY, May 23, 2024 -- Metformin use, including long-term use, is associated with significantly lower odds of myeloproliferative neoplasm (MPN) diagnosis, according to a study...

Metastatic Cancer Survival No Better at Practices With Higher NQF 0210 Rates

WEDNESDAY, May 22, 2024 -- For patients with metastatic or advanced cancer, treatment at practices with higher rates of National Quality Forum (NQF) 0210 (patients receiving...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.